Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

2014 ACR/ARHP Annual Meeting: Fat’s Role in Inflammation

Susan Bernstein  |  Issue: January 2015  |  January 1, 2015

Chronic inflammation may impair the normal engagement of the unfolded protein response (UPR), which is activated in the presence of ER stress. However, these processes do not function normally in an inflammatory environment, such as in obesity. For example, inflammatory signals can modify the function of critical UPR molecules responsible for restoring ER function, such as the splicing of XBP1 by the protein IRE1. In one study, this process did not occur properly in mice, resulting in dysfunctional ER and activation of the JNK pathway, which plays a role in inflammation, Dr. Hotamisligil said. This vicious cycle of inflammation and ER stress also may be seen in beta cells in Type 1 diabetes. Restoring the unfolded protein response in pancreatic beta cells protects mice against diabetes.

Over a lifetime, exposure to obesity and other metabolic stresses can create a bottleneck of macrophages and other immune cells that lead to inflammation. This condition disrupts metabolism and causes further immune activity, launching an endless, vicious cycle, Dr. Hotamisligil said.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“Adipose tissue is a nasty, hostile environment and has lots of noxious cargo. Neither adipocytes nor other critical metabolic cells can operate in full capacity when there is constant immune activity. You can no longer support metabolic homeostasis in a chronic inflammatory environment.” the rheumatologist


Susan Bernstein is a freelance medical journalist based in Atlanta.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsMeeting ReportsOther Rheumatic Conditions Tagged with:2014 ACR/ARHP Annual MeetingBernsteininflammationObesityrheumatology

Related Articles

    Mechanistic, Epidemiologic Clues Suggest Possible Link Between Obesity, Inflammation in Rheumatoid Arthritis

    October 11, 2016

    Obesity has an established systemic inflammatory component. Could that be a trigger for the inflammation seen in rheumatoid arthritis (RA) and other rheumatic diseases? Although there is no direct scientific evidence, both mechanistic and epidemiologic clues do give some intriguing suggestions of a possible link. “At first, we thought that fat was involved only in…

    Gout, Glucose Metabolism and Obesity: A Case Review

    November 2, 2014

    New research explores association between hyperurecimia and gout with metabolic derangement

    AJPhoto / Science Source

    Tips for Diagnosing Metabolic Myopathies

    September 17, 2019

    When evaluating patients with possible myopathic symptoms, rheumatologists must consider a rare, but important, group of inherited disorders: the metabolic myopathies. However, their diagnosis often remains a challenge. Early recognition of these primary metabolic myopathies is essential to help prevent disease morbidity and mortality from rhabdomyolysis. Here, we focus on the metabolic myopathies that present…

    What Do Diabetes, Islet Cells & Autoimmunity Have in Common?

    August 15, 2017

    “Man may be the captain of his fate, but he is also the victim of his blood sugar.” —Wilfrid Oakley, MB BChir, an early pioneer in diabetes care Perusing the list of the most notable medical achievements in the 20th century, a reader may conclude that the discovery of insulin should rank in a category…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences